at Salutetoag.com
About half the women in the study underwent either mastectomy or salpingo-oophorectomy between 1974 and 2008, reducing the risk of proactively cancer. The women were followed for an average of 3.5 years.Furthermore, women who have had their ovaries removed reduced their risk of ovarian cancer and breast cancer, and also lived longer than women who didn t surgery. For example, more than 6 years of follow-up, no cases of ovarian cancer were observed in BRCA2 mutation carriers who underwent bilateral salpingo-oophorectomy, compared with 3 % of carriers which have not undergone the procedure, the ratio of researchers.
According to Rebbeck, doctors usually recommend that women who tested positive for the genes have their ovaries removed at age 35, but agreed with the switch off up to 40 years if no end to have children. He said today, surgery is often done on an outpatient basis, with the use of laparoscopes, which limits scarring and reduced recovery time from a patient s.
The findings are published in the month of September 1 issue of the Journal of the American Medical Association.
However, what our results show that women who choose to have these interventions reduce their risk of dying from breast cancer or ovarian cancer by about 70 to 80 %, which is deep enough, said the lead author of the Dr. Timothy Rebbeck study, professor of epidemiology at the University of Pennsylvania School of Medicine.
., professor of psychiatry at the University of Montreal in Canada, was surprised by the prevalence of behaving in a dream. Sixty-eight % reported being awakened by an erotic dream to find that they were sexually aroused, 72 % had awakened from a dream happy to see that they were actually smile or laugh.
During follow-up, without the occurrence of breast cancer among women with mastectomy, while 7 % of women in the group that didn t have surgery, was diagnosed with breast cancer.
The trial of 22 centers, one of the largest of its kind, studied nearly 2,500 women who were found to have inherited mutations in BRCA1 or BRCA2.
The project in question is the radical removal of the breast or ovaries before any sign of cancer have emerged.
Women who carry these mutations have an increased risk of breast cancer would be between 56 % to 84 %, according to the researchers, while the risk for ovarian cancer ranges by 36 % to 63 % for mutation carriers BRCA1 and 10 % to 27 % for BRCA2 mutation. However, the risk of breast cancer in women is usually about 12 per cent and for ovarian cancer, it’s less than 2 %.
SOURCES: Timothy R. Rebbeck, Ph.D., Professor, Epidemiology, University of Pennsylvania School of Medicine, Philadelphia, Virginia Kaklamanis, MD, director of translational breast cancer, Robert H. Lurie Comprehensive Cancer Center and associate professor of medicine at Northwestern University, Chicago, Daniel Silver, MD, Ph.D., Professor of Medicine, Dana Farber Cancer Institute, Harvard Medical School, Cambridge, Mass., Sept.
Women who carry the genetic mutations that increase their chances of breast cancer and ovarian cancer can live longer and reduce their risk of cancer prevention by surgery, a new study suggests.